2022 Research Highlights — Human Health Advances
NIH accomplishments in disease prevention, diagnosis, and treatment include insights into Covid-19 vaccines, advances for type 1 diabetes, and a robotic exoskeleton that helps people walk. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - December 20, 2022 Category: Consumer Health News Source Type: news
A Starting Point for Precision Medicine in Type 1 Diabetes A Starting Point for Precision Medicine in Type 1 Diabetes
New evidence about the epidemiology, genetics, and possible constituent causes of type 1 diabetes is offering clues to precision medicine for this disorder.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 16, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Insulin Pumps Ease Diabetes Care. So Why Are Black Patients Less Likely to Get One?
TUESDAY, Dec. 13, 2022 -- Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years.
That ' s the good news from a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2022 Category: General Medicine Source Type: news
Impaired postural control in diabetes-a predictor of falls? - Rasmussen NHH, Dal J, Jensen MH, Kvist AV, van den Bergh J, Hirata RP, Vestergaard P.
New evidence points toward that impaired postural control judged by center of pressure measures during quiet stance is a predictor of falls in people with type 1 and type 2 diabetes-even in occurrence of well-known risk factors for falls.
INTRODUCTION/... (Source: SafetyLit)
Source: SafetyLit - December 12, 2022 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
3 things to know about teplizumb, the new diabetes drug
Yale endocrinologist Kevan Herold discusses an important new treatment that delays the onset of type 1 diabetes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 8, 2022 Category: Universities & Medical Training Source Type: news
3 things to know about teplizumab, the new diabetes drug
Yale endocrinologist Kevan Herold discusses an important new treatment that delays the onset of type 1 diabetes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 8, 2022 Category: Universities & Medical Training Source Type: news
Bromocriptine Improves Vascular Health in Type 1 Diabetes Bromocriptine Improves Vascular Health in Type 1 Diabetes
Bromocriptine quick release improves blood pressure and central aortic stiffness in adolescents with type 1 diabetes, potentially decreasing CVD risk in this population.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 8, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Type 1 Diabetes Doesn't Have to Hold Kids Back in School
WEDNESDAY, Dec. 7, 2022 -- Children with type 1 diabetes miss more school than their peers without this condition, but the good news is these absences don’t have to affect their grades or chances of going on to college, new research... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2022 Category: General Medicine Source Type: news
TDSB providing only 'half measures' to protect at-risk 4-year-old with diabetes, mom says
A Toronto mother says she's been trying to get long-term staffing support for her four-year-old son who has Type 1 Diabetes for nearly a year. The Canadian Paediatric Society says the situation isn't uncommon. (Source: CBC | Health)
Source: CBC | Health - December 7, 2022 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
Educational Attainment No Worse for Children With T1DM
TUESDAY, Dec. 6, 2022 -- Children with type 1 diabetes do not have worse educational attainment or entry into higher education, despite missing more school, according to a study published in the December issue of Diabetes Care.
Robert French, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2022 Category: Pharmaceuticals Source Type: news
Bromocriptine Quick Release Beneficial for Teens With T1DM
TUESDAY, Dec. 6, 2022 -- For adolescents with type 1 diabetes (T1D), bromocriptine quick release (BCQR) improves blood pressure and central and peripheral aortic stiffness, according to a study published online Dec. 6 in Hypertension.
Michal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2022 Category: Pharmaceuticals Source Type: news
Diabetes Boosts Postoperative Opioid Use Diabetes Boosts Postoperative Opioid Use
People with diabetes, especially those with type 1 diabetes, were significantly more likely to have prolonged opioid use following surgery compared to people without diabetes who underwent surgery.First Look (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 6, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
With Type 1 Diabetes Delay Possible, Focus Now on Screening With Type 1 Diabetes Delay Possible, Focus Now on Screening
The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost-effectively identify those at risk who could potentially receive it.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 30, 2022 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
' First Step' Toward Delaying Progression of Type 1 Diabetes'First Step' Toward Delaying Progression of Type 1 Diabetes
Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 22, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
A cell biologist shares the wonder of researching life's most fundamental form
Physician Siddhartha Mukherjee explains how cellular science could lead to breakthroughs in the treatment of cancer, HIV, Type 1 diabetes and sickle cell anemia. His new book is The Song of the Cell.(Image credit: Simon & Schuster) (Source: NPR Health and Science)
Source: NPR Health and Science - November 21, 2022 Category: Consumer Health News Authors: Terry Gross Source Type: news
